Shenzhen Viatom Technology Co., Ltd.: FDA filings under this applicant name
FDA lists 5 510(k) clearances under the applicant name “Shenzhen Viatom Technology Co., Ltd.” (first 2019, latest 2025), across 2 product codes in 2 review panels. Median 510(k) review time under this name: 205 days. Since 2017 the median was 205 days, against 182 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2019 | 2 | 209 |
| 2020 | 1 | 205 |
| 2021 | 0 | — |
| 2022 | 1 | 680 |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 1 | 158 |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Shenzhen Viatom Technology Co., Ltd. took a median 205 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 182 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| DQA | Oximeter | 3 | 3 |
| DXN | System, Measurement, Blood-Pressure, Non-Invasive | 2 | 2 |
Review panels
- Anesthesiology (3)
- Cardiovascular (2)
Most recent Shenzhen Viatom Technology Co., Ltd. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K242876 | Pulse Oximeter ( PO2, PO2A, PO2B) | DQA | 2025-02-28 | 158 |
| K203812 | Oxyfit Pulse Oximeter | DQA | 2022-11-08 | 680 |
| K193348 | Blood Pressure Monitor | DXN | 2020-06-25 | 205 |
| K191088 | Checkme O2 Pulse Oximeter | DQA | 2019-12-02 | 222 |
| K190207 | Blood Pressure Monitor | DXN | 2019-08-19 | 196 |
Recalls
openFDA lists no recalls under a recalling firm named Shenzhen Viatom Technology Co., Ltd..
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (160 510(k)s)
- Shenzhen Dongdixin Technology Co., Ltd. (26 510(k)s)
- Shenzhen Kaiyan Medical Equipment Co., Ltd. (24 510(k)s)
- Shenzhen TPH Technology Co., Ltd. (24 510(k)s)
- Shenzhen Ulike Smart Electronics Co., Ltd. (23 510(k)s)
- Shenzhen AOJ Medical Technology Co., Ltd. (17 510(k)s)
- Shenzhen Beacon Display Technology Co., Ltd. (17 510(k)s)
- Shenzhen Med-Link Electronics Tech Co., Ltd. (14 510(k)s)
- Shenzhen RF Tech Co., Ltd. (12 510(k)s)
- Shenzhen Root Innovation Technology Co., Ltd. (12 510(k)s)
- Shenzhen Creative Industry Co., Ltd. (11 510(k)s)
- Shenzhen Jumper Medical Equipment Co., Ltd. (10 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Shenzhen Viatom Technology Co., Ltd.?
FDA lists 5 510(k) clearances under the applicant name “Shenzhen Viatom Technology Co., Ltd.” (first 2019, latest 2025), across 2 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Shenzhen Viatom Technology Co., Ltd.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Shenzhen Viatom Technology Co., Ltd. is 205 days. Since 2017: 205 days, versus 182 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Shenzhen Viatom Technology Co., Ltd.?
The most frequent FDA product codes under this applicant name are DQA (Oximeter, 3); DXN (System, Measurement, Blood-Pressure, Non-Invasive, 2).
Next steps
- See all 5 Shenzhen Viatom Technology Co., Ltd. clearances with predicates and recalls
- Run predicate analysis for product code DQA, Shenzhen Viatom Technology Co., Ltd.'s most frequent
Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name, with punctuation and legal suffixes removed; filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.